Due to dysfunctions of the serotonergic system associated with severe neuropsychiatric disorders like depression or anxiety, SERT represents an important target for both clinically relevant drugs like antidepressants and anxiolytic medicines, but also recreational drugs (Kristensen et al. 2011). The gene discussed is SLC6A4; the disease is Anxiety.